Benitec Biopharma Ltd Stock Investor Sentiment

BNTC Stock  USD 16.79  1.13  7.22%   
About 56% of all Benitec Biopharma's shareholders are looking to take a long position. The analysis of the overall investor sentiment regarding Benitec Biopharma Ltd suggests that some traders are interested. The current market sentiment, together with Benitec Biopharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Benitec Biopharma stock news signals to limit their universe of possible portfolio assets.
  
2 days ago at finance.yahoo.com         
Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated with BB-301 i...
Yahoo News
2 days ago at thelincolnianonline.com         
Benitec Biopharma Inc. Short Interest Up 17.6 percent in February
news
3 days ago at news.google.com         
Benitec stock holds 18 target, Market Outperform rating By Investing.com - Investing.com UK
Google News at Macroaxis
over a week ago at talkmarkets.com         
Benitec - Another Biopharma Rocket
news
over a week ago at zacks.com         
Has Arcutis Biotherapeutics Outpaced Other Medical Stocks This Year?
zacks News
over a week ago at zacks.com         
Disposition of 103626 shares by Buchi J Kevin of Benitec Biopharma subject to Rule 16b-3
zacks News
over a week ago at news.google.com         
Benitec Biopharma stock soars to 52-week high of 13.32 By Investing.com - Investing.com South Africa
Google News at Macroaxis
over a week ago at finance.yahoo.com         
Benitec Biopharma Is In A Good Position To Deliver On Growth Plans
Yahoo News
over two weeks ago at www.macroaxis.com         
Disposition of 51813 shares by Buchi J Kevin of Benitec Biopharma at 3.86 subject to Rule 16b-3
Macroaxis News
over three weeks ago at gurufocus.com         
Benitec Biopharma to Participate in Upcoming Conferences in March
Gurufocus Stories at Macroaxis
over three weeks ago at news.google.com         
Benitec Biopharmas SWOT analysis gene therapy stock shows promise amid trials By Investing.com - Inv...
Google News at Macroaxis
over three weeks ago at news.google.com         
Wall Street Analysts Predict a 127.26 percent Upside in Benitec Biopharma Heres What You Should Know...
Google News at Macroaxis
over three weeks ago at news.google.com         
H.C. Wainwright maintains 28 target on Benitec BioPharma stock - Investing.com
Google News at Macroaxis
over three weeks ago at finance.yahoo.com         
Wall Street Analysts Predict a 127.26 percent Upside in Benitec Biopharma Heres What You Should Know
Yahoo News
over three weeks ago at finance.yahoo.com         
Benitec Biopharma is on the Move, Heres Why the Trend Could be Sustainable
Yahoo News
Far too much social signal, news, headlines, and media speculation about Benitec Biopharma that are available to investors today. That information is available publicly through Benitec media outlets and privately through word of mouth or via Benitec internal channels. However, regardless of the origin, that massive amount of Benitec data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Benitec Biopharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Benitec Biopharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Benitec Biopharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Benitec Biopharma alpha.

Benitec Biopharma Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Benitec Stock analysis

When running Benitec Biopharma's price analysis, check to measure Benitec Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Benitec Biopharma is operating at the current time. Most of Benitec Biopharma's value examination focuses on studying past and present price action to predict the probability of Benitec Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Benitec Biopharma's price. Additionally, you may evaluate how the addition of Benitec Biopharma to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data